We are working to invent the next generation of targeted therapeutics using our broad range of modalities to develop molecules that provide the most robust response to the diseases we target. Our deep expertise in molecular engineering enables us to tackle challenging and previously untreatable conditions.
Depending on the disease target, our teams employ diverse approaches, including complex biotherapeutics, small molecules and gene-silencing siRNA therapeutics, to deliver more precise and more effective therapies to patients.
